| 1 | intravenous | 13,381 |
| 2 | intrathecal | 935 |
| 3 | intracoronary | 908 |
| 4 | intra-arterial | 459 |
| 5 | intraarterial | 115 |
| 6 | intrapleural | 109 |
| 7 | intrarectal | 52 |
| 8 | intracystic | 41 |
| 9 | intravenous/oral | 26 |
| 10 | around-the-clock | 25 |
| 11 | chronomodulated | 17 |
| 12 | large-dose | 15 |
| 13 | intrabrachial | 14 |
| 14 | intrapericardial | 13 |
| 15 | intraruminal | 13 |
| 16 | air-driven | 12 |
| 17 | fms-related | 12 |
| 18 | albumin-containing | 11 |
| 19 | intracolonic | 11 |
| 20 | heliox-driven | 10 |
| 21 | intrajejunal | 10 |
| 22 | 14c-labeled | 9 |
| 23 | mailuo | 9 |
| 24 | saline-based | 9 |
| 25 | ultrasound-enhanced | 9 |
| 26 | intra-amygdala | 8 |
| 27 | oil-free | 8 |
| 28 | equiosmolar | 7 |
| 29 | qishenyiqi | 7 |
| 30 | 'intravenous | 6 |
| 31 | definity | 6 |
| 32 | epineural | 6 |
| 33 | oxygen-driven | 6 |
| 34 | prison-initiated | 6 |
| 35 | post-aki | 5 |
| 36 | ranibizumab/sham | 5 |
| 37 | alum-formulated | 4 |
| 38 | anti-rotaviral | 4 |
| 39 | belt-positioning | 4 |
| 40 | dual-wave | 4 |
| 41 | gas-forced | 4 |
| 42 | gbcm | 4 |
| 43 | intra-vesical | 4 |
| 44 | intrathrombus | 4 |
| 45 | manual-controlled | 4 |
| 46 | o2/n2o | 4 |
| 47 | pre-bypass | 4 |
| 48 | unincorporated | 4 |
| 49 | us-accelerated | 4 |
| 50 | 3-carboranyl | 3 |
| 51 | as03a-h5n1 | 3 |
| 52 | bencard | 3 |
| 53 | cardiac-directed | 3 |
| 54 | hypoosmolar | 3 |
| 55 | intra-pleural | 3 |
| 56 | ischemia/5-min | 3 |
| 57 | leukocyte-poor | 3 |
| 58 | myeloid-epithelial-reproductive | 3 |
| 59 | non-liposomal | 3 |
| 60 | nonanesthesiologist-administered | 3 |
| 61 | open-vent | 3 |
| 62 | pharmacological-induced | 3 |
| 63 | slow-drop | 3 |
| 64 | slow-released | 3 |
| 65 | 5000-iu | 2 |
| 66 | 56mg/kg | 2 |
| 67 | acylureido | 2 |
| 68 | bdnf-neurotrophic | 2 |
| 69 | buprenorphine/ | 2 |
| 70 | caerulein | 2 |
| 71 | carbon-assisted | 2 |
| 72 | central-venous | 2 |
| 73 | cold-stored | 2 |
| 74 | corrections-based | 2 |
| 75 | cvc-peripheral | 2 |
| 76 | d-chiro | 2 |
| 77 | decanoyl | 2 |
| 78 | disposable-syringe | 2 |
| 79 | distigmine | 2 |
| 80 | dye-assisted | 2 |
| 81 | elastometric | 2 |
| 82 | endoscopist-directed | 2 |
| 83 | genotype-adjusted | 2 |
| 84 | high-back | 2 |
| 85 | high-sustained | 2 |
| 86 | hypertensive- | 2 |
| 87 | immediaterelease | 2 |
| 88 | intra-annular | 2 |
| 89 | intra-pag | 2 |
| 90 | intra-thecal | 2 |
| 91 | intramuscular/subcutaneous | 2 |
| 92 | intraputaminal | 2 |
| 93 | intrarterial | 2 |
| 94 | iv/ia | 2 |
| 95 | membrane-initiated | 2 |
| 96 | neoral-based | 2 |
| 97 | non-intravenous | 2 |
| 98 | nonfemoral | 2 |
| 99 | oral/sublingual | 2 |
| 100 | oversulfated | 2 |
| 101 | patient-maintained | 2 |
| 102 | perisciatic | 2 |
| 103 | post-intradermal | 2 |
| 104 | post-iv | 2 |
| 105 | prehopsital | 2 |
| 106 | propineb | 2 |
| 107 | rgs-insensitive | 2 |
| 108 | riboprotein | 2 |
| 109 | slab-derived | 2 |
| 110 | sublingual/oral | 2 |
| 111 | tenascin-c. | 2 |
| 112 | three-times-a-week | 2 |
| 113 | tragopogon | 2 |
| 114 | transmitralic | 2 |
| 115 | uncountable | 2 |
| 116 | /100-microgram | 1 |
| 117 | 1-2-hour | 1 |
| 118 | 1.9-μg | 1 |
| 119 | 1.h-1 | 1 |
| 120 | 10u | 1 |
| 121 | 11.1mg | 1 |
| 122 | 112mg | 1 |
| 123 | 12-μg/h | 1 |
| 124 | 15-oh-lactone | 1 |
| 125 | 160-detector | 1 |
| 126 | 2'-o-propargylated | 1 |
| 127 | 2-5a-dependent | 1 |
| 128 | 2-6-h | 1 |
| 129 | 20/sps1-related | 1 |
| 130 | 2040.40 | 1 |
| 131 | 22-mg | 1 |
| 132 | 240μg | 1 |
| 133 | 25-mg/m2 | 1 |
| 134 | 2mg/bolus | 1 |
| 135 | 3,3',5'-trialkylsubstitued | 1 |
| 136 | 3,3',5'-trisubstitued | 1 |
| 137 | 3-ml/kg | 1 |
| 138 | 36-hr | 1 |
| 139 | 62mg | 1 |
| 140 | 85-u/kg | 1 |
| 141 | alternate-daily-dosed | 1 |
| 142 | amebicides | 1 |
| 143 | anp-stimulated | 1 |
| 144 | anti-sftsv | 1 |
| 145 | antibiotin | 1 |
| 146 | at1/apoptosis | 1 |
| 147 | auc0-∞of | 1 |
| 148 | bent-over | 1 |
| 149 | beta-ar-stimulated | 1 |
| 150 | bolus/44-h | 1 |
| 151 | brucella-specific | 1 |
| 152 | bud/form+as-needed | 1 |
| 153 | c-june | 1 |
| 154 | catecholamine-sensitive | 1 |
| 155 | chemical/mechanical | 1 |
| 156 | colloid/crystalloid | 1 |
| 157 | conventional-dose-weight | 1 |
| 158 | daily-observed | 1 |
| 159 | device-aided | 1 |
| 160 | donor-feces | 1 |
| 161 | dose-weight | 1 |
| 162 | dox/dnr | 1 |
| 163 | drill-generated | 1 |
| 164 | dtpa-hbv/hib | 1 |
| 165 | epa/120-mg | 1 |
| 166 | erbb-4 | 1 |
| 167 | fenofibrate-loaded | 1 |
| 168 | fins-like | 1 |
| 169 | fms‑like | 1 |
| 170 | fpm-1-labile | 1 |
| 171 | gcsfs | 1 |
| 172 | glucose-potassium-insulin | 1 |
| 173 | groups.rectal | 1 |
| 174 | gαi-coupled | 1 |
| 175 | hepaticartery | 1 |
| 176 | heterohexameric | 1 |
| 177 | hf-plasma | 1 |
| 178 | hib/mcc-tt | 1 |
| 179 | hxrxxs/t | 1 |
| 180 | immunostimulant-inducing | 1 |
| 181 | inhalation-triggered | 1 |
| 182 | intra-pulmonary | 1 |
| 183 | intra-striatal | 1 |
| 184 | intra-vlpag | 1 |
| 185 | intramesenteric | 1 |
| 186 | intratechal | 1 |
| 187 | intravenosus | 1 |
| 188 | intravenous/intramuscular | 1 |
| 189 | introgastric | 1 |
| 190 | ischaemia/75-min | 1 |
| 191 | ischemia/45-min | 1 |
| 192 | isotopic-tracer | 1 |
| 193 | l-essential | 1 |
| 194 | lymphoid-specific | 1 |
| 195 | mediastinum.the | 1 |
| 196 | metal-capped | 1 |
| 197 | micro-impinging | 1 |
| 198 | mnps-fe₃o₄and/or | 1 |
| 199 | multi-specific | 1 |
| 200 | mycoardial | 1 |
| 201 | naloxan | 1 |
| 202 | no-soluble | 1 |
| 203 | no/soluble | 1 |
| 204 | non-treatment-limiting | 1 |
| 205 | oa/no | 1 |
| 206 | occlusion/10-minute | 1 |
| 207 | oculab | 1 |
| 208 | opioid-antagonist | 1 |
| 209 | osfkbp65-related | 1 |
| 210 | p-p70 | 1 |
| 211 | parturientsgiven | 1 |
| 212 | pcv13-elicited | 1 |
| 213 | peripherally-injected | 1 |
| 214 | pharamacologic | 1 |
| 215 | pharmaco-mechanical | 1 |
| 216 | post-23vps | 1 |
| 217 | post-capsule | 1 |
| 218 | post-mdma | 1 |
| 219 | post-nadir | 1 |
| 220 | post-radiotracer | 1 |
| 221 | post-rvwf-rfviii | 1 |
| 222 | predopamine | 1 |
| 223 | propofolremifentanil | 1 |
| 224 | public-access | 1 |
| 225 | q565e | 1 |
| 226 | rac-alpha | 1 |
| 227 | rubber-ring | 1 |
| 228 | sb-based | 1 |
| 229 | selenium-rich | 1 |
| 230 | soluble/free | 1 |
| 231 | tace/intra-arterial | 1 |
| 232 | test-product | 1 |
| 233 | three-faced | 1 |
| 234 | tri-associated | 1 |
| 235 | tri-sodium-citrate | 1 |
| 236 | ubiquitylate | 1 |
| 237 | ucmsc | 1 |
| 238 | ul13-dependent | 1 |
| 239 | unconsummated | 1 |
| 240 | upfront-pre-procedural-abciximab | 1 |
| 241 | warm-ischemia | 1 |
| 242 | warmed-fluid | 1 |
| 243 | α-fluoromethyl | 1 |
| 244 | ≥30-mg | 1 |
| 1 | 'intravenous | 6 |
| 2 | /100-microgram | 1 |
| 3 | 1-2-hour | 1 |
| 4 | 1.9-μg | 1 |
| 5 | 1.h-1 | 1 |
| 6 | 10u | 1 |
| 7 | 11.1mg | 1 |
| 8 | 112mg | 1 |
| 9 | 12-μg/h | 1 |
| 10 | 14c-labeled | 9 |
| 11 | 15-oh-lactone | 1 |
| 12 | 160-detector | 1 |
| 13 | 2'-o-propargylated | 1 |
| 14 | 2-5a-dependent | 1 |
| 15 | 2-6-h | 1 |
| 16 | 20/sps1-related | 1 |
| 17 | 2040.40 | 1 |
| 18 | 22-mg | 1 |
| 19 | 240μg | 1 |
| 20 | 25-mg/m2 | 1 |
| 21 | 2mg/bolus | 1 |
| 22 | 3,3',5'-trialkylsubstitued | 1 |
| 23 | 3,3',5'-trisubstitued | 1 |
| 24 | 3-carboranyl | 3 |
| 25 | 3-ml/kg | 1 |
| 26 | 36-hr | 1 |
| 27 | 5000-iu | 2 |
| 28 | 56mg/kg | 2 |
| 29 | 62mg | 1 |
| 30 | 85-u/kg | 1 |
| 31 | acylureido | 2 |
| 32 | air-driven | 12 |
| 33 | albumin-containing | 11 |
| 34 | alternate-daily-dosed | 1 |
| 35 | alum-formulated | 4 |
| 36 | amebicides | 1 |
| 37 | anp-stimulated | 1 |
| 38 | anti-rotaviral | 4 |
| 39 | anti-sftsv | 1 |
| 40 | antibiotin | 1 |
| 41 | around-the-clock | 25 |
| 42 | as03a-h5n1 | 3 |
| 43 | at1/apoptosis | 1 |
| 44 | auc0-∞of | 1 |
| 45 | bdnf-neurotrophic | 2 |
| 46 | belt-positioning | 4 |
| 47 | bencard | 3 |
| 48 | bent-over | 1 |
| 49 | beta-ar-stimulated | 1 |
| 50 | bolus/44-h | 1 |
| 51 | brucella-specific | 1 |
| 52 | bud/form+as-needed | 1 |
| 53 | buprenorphine/ | 2 |
| 54 | c-june | 1 |
| 55 | caerulein | 2 |
| 56 | carbon-assisted | 2 |
| 57 | cardiac-directed | 3 |
| 58 | catecholamine-sensitive | 1 |
| 59 | central-venous | 2 |
| 60 | chemical/mechanical | 1 |
| 61 | chronomodulated | 17 |
| 62 | cold-stored | 2 |
| 63 | colloid/crystalloid | 1 |
| 64 | conventional-dose-weight | 1 |
| 65 | corrections-based | 2 |
| 66 | cvc-peripheral | 2 |
| 67 | d-chiro | 2 |
| 68 | daily-observed | 1 |
| 69 | decanoyl | 2 |
| 70 | definity | 6 |
| 71 | device-aided | 1 |
| 72 | disposable-syringe | 2 |
| 73 | distigmine | 2 |
| 74 | donor-feces | 1 |
| 75 | dose-weight | 1 |
| 76 | dox/dnr | 1 |
| 77 | drill-generated | 1 |
| 78 | dtpa-hbv/hib | 1 |
| 79 | dual-wave | 4 |
| 80 | dye-assisted | 2 |
| 81 | elastometric | 2 |
| 82 | endoscopist-directed | 2 |
| 83 | epa/120-mg | 1 |
| 84 | epineural | 6 |
| 85 | equiosmolar | 7 |
| 86 | erbb-4 | 1 |
| 87 | fenofibrate-loaded | 1 |
| 88 | fins-like | 1 |
| 89 | fms-related | 12 |
| 90 | fms‑like | 1 |
| 91 | fpm-1-labile | 1 |
| 92 | gas-forced | 4 |
| 93 | gbcm | 4 |
| 94 | gcsfs | 1 |
| 95 | genotype-adjusted | 2 |
| 96 | glucose-potassium-insulin | 1 |
| 97 | groups.rectal | 1 |
| 98 | gαi-coupled | 1 |
| 99 | heliox-driven | 10 |
| 100 | hepaticartery | 1 |
| 101 | heterohexameric | 1 |
| 102 | hf-plasma | 1 |
| 103 | hib/mcc-tt | 1 |
| 104 | high-back | 2 |
| 105 | high-sustained | 2 |
| 106 | hxrxxs/t | 1 |
| 107 | hypertensive- | 2 |
| 108 | hypoosmolar | 3 |
| 109 | immediaterelease | 2 |
| 110 | immunostimulant-inducing | 1 |
| 111 | inhalation-triggered | 1 |
| 112 | intra-amygdala | 8 |
| 113 | intra-annular | 2 |
| 114 | intra-arterial | 459 |
| 115 | intra-pag | 2 |
| 116 | intra-pleural | 3 |
| 117 | intra-pulmonary | 1 |
| 118 | intra-striatal | 1 |
| 119 | intra-thecal | 2 |
| 120 | intra-vesical | 4 |
| 121 | intra-vlpag | 1 |
| 122 | intraarterial | 115 |
| 123 | intrabrachial | 14 |
| 124 | intracolonic | 11 |
| 125 | intracoronary | 908 |
| 126 | intracystic | 41 |
| 127 | intrajejunal | 10 |
| 128 | intramesenteric | 1 |
| 129 | intramuscular/subcutaneous | 2 |
| 130 | intrapericardial | 13 |
| 131 | intrapleural | 109 |
| 132 | intraputaminal | 2 |
| 133 | intrarectal | 52 |
| 134 | intrarterial | 2 |
| 135 | intraruminal | 13 |
| 136 | intratechal | 1 |
| 137 | intrathecal | 935 |
| 138 | intrathrombus | 4 |
| 139 | intravenosus | 1 |
| 140 | intravenous | 13,381 |
| 141 | intravenous/intramuscular | 1 |
| 142 | intravenous/oral | 26 |
| 143 | introgastric | 1 |
| 144 | ischaemia/75-min | 1 |
| 145 | ischemia/45-min | 1 |
| 146 | ischemia/5-min | 3 |
| 147 | isotopic-tracer | 1 |
| 148 | iv/ia | 2 |
| 149 | l-essential | 1 |
| 150 | large-dose | 15 |
| 151 | leukocyte-poor | 3 |
| 152 | lymphoid-specific | 1 |
| 153 | mailuo | 9 |
| 154 | manual-controlled | 4 |
| 155 | mediastinum.the | 1 |
| 156 | membrane-initiated | 2 |
| 157 | metal-capped | 1 |
| 158 | micro-impinging | 1 |
| 159 | mnps-fe₃o₄and/or | 1 |
| 160 | multi-specific | 1 |
| 161 | mycoardial | 1 |
| 162 | myeloid-epithelial-reproductive | 3 |
| 163 | naloxan | 1 |
| 164 | neoral-based | 2 |
| 165 | no-soluble | 1 |
| 166 | no/soluble | 1 |
| 167 | non-intravenous | 2 |
| 168 | non-liposomal | 3 |
| 169 | non-treatment-limiting | 1 |
| 170 | nonanesthesiologist-administered | 3 |
| 171 | nonfemoral | 2 |
| 172 | o2/n2o | 4 |
| 173 | oa/no | 1 |
| 174 | occlusion/10-minute | 1 |
| 175 | oculab | 1 |
| 176 | oil-free | 8 |
| 177 | open-vent | 3 |
| 178 | opioid-antagonist | 1 |
| 179 | oral/sublingual | 2 |
| 180 | osfkbp65-related | 1 |
| 181 | oversulfated | 2 |
| 182 | oxygen-driven | 6 |
| 183 | p-p70 | 1 |
| 184 | parturientsgiven | 1 |
| 185 | patient-maintained | 2 |
| 186 | pcv13-elicited | 1 |
| 187 | peripherally-injected | 1 |
| 188 | perisciatic | 2 |
| 189 | pharamacologic | 1 |
| 190 | pharmaco-mechanical | 1 |
| 191 | pharmacological-induced | 3 |
| 192 | post-23vps | 1 |
| 193 | post-aki | 5 |
| 194 | post-capsule | 1 |
| 195 | post-intradermal | 2 |
| 196 | post-iv | 2 |
| 197 | post-mdma | 1 |
| 198 | post-nadir | 1 |
| 199 | post-radiotracer | 1 |
| 200 | post-rvwf-rfviii | 1 |
| 201 | pre-bypass | 4 |
| 202 | predopamine | 1 |
| 203 | prehopsital | 2 |
| 204 | prison-initiated | 6 |
| 205 | propineb | 2 |
| 206 | propofolremifentanil | 1 |
| 207 | public-access | 1 |
| 208 | q565e | 1 |
| 209 | qishenyiqi | 7 |
| 210 | rac-alpha | 1 |
| 211 | ranibizumab/sham | 5 |
| 212 | rgs-insensitive | 2 |
| 213 | riboprotein | 2 |
| 214 | rubber-ring | 1 |
| 215 | saline-based | 9 |
| 216 | sb-based | 1 |
| 217 | selenium-rich | 1 |
| 218 | slab-derived | 2 |
| 219 | slow-drop | 3 |
| 220 | slow-released | 3 |
| 221 | soluble/free | 1 |
| 222 | sublingual/oral | 2 |
| 223 | tace/intra-arterial | 1 |
| 224 | tenascin-c. | 2 |
| 225 | test-product | 1 |
| 226 | three-faced | 1 |
| 227 | three-times-a-week | 2 |
| 228 | tragopogon | 2 |
| 229 | transmitralic | 2 |
| 230 | tri-associated | 1 |
| 231 | tri-sodium-citrate | 1 |
| 232 | ubiquitylate | 1 |
| 233 | ucmsc | 1 |
| 234 | ul13-dependent | 1 |
| 235 | ultrasound-enhanced | 9 |
| 236 | unconsummated | 1 |
| 237 | uncountable | 2 |
| 238 | unincorporated | 4 |
| 239 | upfront-pre-procedural-abciximab | 1 |
| 240 | us-accelerated | 4 |
| 241 | warm-ischemia | 1 |
| 242 | warmed-fluid | 1 |
| 243 | α-fluoromethyl | 1 |
| 244 | ≥30-mg | 1 |
| 1 | hypertensive- | 2 |
| 2 | tenascin-c. | 2 |
| 3 | buprenorphine/ | 2 |
| 4 | 2040.40 | 1 |
| 5 | p-p70 | 1 |
| 6 | 1.h-1 | 1 |
| 7 | as03a-h5n1 | 3 |
| 8 | 25-mg/m2 | 1 |
| 9 | erbb-4 | 1 |
| 10 | rac-alpha | 1 |
| 11 | iv/ia | 2 |
| 12 | warm-ischemia | 1 |
| 13 | intra-amygdala | 8 |
| 14 | post-mdma | 1 |
| 15 | hf-plasma | 1 |
| 16 | oculab | 1 |
| 17 | upfront-pre-procedural-abciximab | 1 |
| 18 | propineb | 2 |
| 19 | dtpa-hbv/hib | 1 |
| 20 | brucella-specific | 1 |
| 21 | lymphoid-specific | 1 |
| 22 | multi-specific | 1 |
| 23 | pharamacologic | 1 |
| 24 | bdnf-neurotrophic | 2 |
| 25 | transmitralic | 2 |
| 26 | intracolonic | 11 |
| 27 | heterohexameric | 1 |
| 28 | intramesenteric | 1 |
| 29 | elastometric | 2 |
| 30 | introgastric | 1 |
| 31 | perisciatic | 2 |
| 32 | intracystic | 41 |
| 33 | ucmsc | 1 |
| 34 | three-faced | 1 |
| 35 | ultrasound-enhanced | 9 |
| 36 | gas-forced | 4 |
| 37 | pharmacological-induced | 3 |
| 38 | fenofibrate-loaded | 1 |
| 39 | bud/form+as-needed | 1 |
| 40 | device-aided | 1 |
| 41 | 14c-labeled | 9 |
| 42 | manual-controlled | 4 |
| 43 | gαi-coupled | 1 |
| 44 | patient-maintained | 2 |
| 45 | high-sustained | 2 |
| 46 | metal-capped | 1 |
| 47 | inhalation-triggered | 1 |
| 48 | nonanesthesiologist-administered | 3 |
| 49 | cold-stored | 2 |
| 50 | sb-based | 1 |
| 51 | saline-based | 9 |
| 52 | neoral-based | 2 |
| 53 | corrections-based | 2 |
| 54 | slow-released | 3 |
| 55 | alternate-daily-dosed | 1 |
| 56 | oversulfated | 2 |
| 57 | tri-associated | 1 |
| 58 | membrane-initiated | 2 |
| 59 | prison-initiated | 6 |
| 60 | 20/sps1-related | 1 |
| 61 | osfkbp65-related | 1 |
| 62 | fms-related | 12 |
| 63 | chronomodulated | 17 |
| 64 | anp-stimulated | 1 |
| 65 | beta-ar-stimulated | 1 |
| 66 | alum-formulated | 4 |
| 67 | 2'-o-propargylated | 1 |
| 68 | unconsummated | 1 |
| 69 | us-accelerated | 4 |
| 70 | drill-generated | 1 |
| 71 | unincorporated | 4 |
| 72 | peripherally-injected | 1 |
| 73 | cardiac-directed | 3 |
| 74 | endoscopist-directed | 2 |
| 75 | pcv13-elicited | 1 |
| 76 | dye-assisted | 2 |
| 77 | carbon-assisted | 2 |
| 78 | genotype-adjusted | 2 |
| 79 | 3,3',5'-trisubstitued | 1 |
| 80 | 3,3',5'-trialkylsubstitued | 1 |
| 81 | slab-derived | 2 |
| 82 | daily-observed | 1 |
| 83 | colloid/crystalloid | 1 |
| 84 | warmed-fluid | 1 |
| 85 | bencard | 3 |
| 86 | q565e | 1 |
| 87 | oil-free | 8 |
| 88 | soluble/free | 1 |
| 89 | disposable-syringe | 2 |
| 90 | mediastinum.the | 1 |
| 91 | fins-like | 1 |
| 92 | fms‑like | 1 |
| 93 | uncountable | 2 |
| 94 | no-soluble | 1 |
| 95 | no/soluble | 1 |
| 96 | fpm-1-labile | 1 |
| 97 | post-capsule | 1 |
| 98 | predopamine | 1 |
| 99 | distigmine | 2 |
| 100 | 15-oh-lactone | 1 |
| 101 | c-june | 1 |
| 102 | immediaterelease | 2 |
| 103 | large-dose | 15 |
| 104 | ubiquitylate | 1 |
| 105 | tri-sodium-citrate | 1 |
| 106 | occlusion/10-minute | 1 |
| 107 | dual-wave | 4 |
| 108 | myeloid-epithelial-reproductive | 3 |
| 109 | catecholamine-sensitive | 1 |
| 110 | rgs-insensitive | 2 |
| 111 | auc0-∞of | 1 |
| 112 | intra-pag | 2 |
| 113 | intra-vlpag | 1 |
| 114 | 56mg/kg | 2 |
| 115 | 3-ml/kg | 1 |
| 116 | 85-u/kg | 1 |
| 117 | epa/120-mg | 1 |
| 118 | ≥30-mg | 1 |
| 119 | 22-mg | 1 |
| 120 | 11.1mg | 1 |
| 121 | 112mg | 1 |
| 122 | 62mg | 1 |
| 123 | immunostimulant-inducing | 1 |
| 124 | micro-impinging | 1 |
| 125 | albumin-containing | 11 |
| 126 | belt-positioning | 4 |
| 127 | rubber-ring | 1 |
| 128 | non-treatment-limiting | 1 |
| 129 | 1.9-μg | 1 |
| 130 | 240μg | 1 |
| 131 | bolus/44-h | 1 |
| 132 | 2-6-h | 1 |
| 133 | 12-μg/h | 1 |
| 134 | selenium-rich | 1 |
| 135 | post-rvwf-rfviii | 1 |
| 136 | post-aki | 5 |
| 137 | qishenyiqi | 7 |
| 138 | high-back | 2 |
| 139 | around-the-clock | 25 |
| 140 | three-times-a-week | 2 |
| 141 | intra-thecal | 2 |
| 142 | intrathecal | 935 |
| 143 | pharmaco-mechanical | 1 |
| 144 | chemical/mechanical | 1 |
| 145 | intra-vesical | 4 |
| 146 | intratechal | 1 |
| 147 | intrapericardial | 13 |
| 148 | mycoardial | 1 |
| 149 | intrabrachial | 14 |
| 150 | intra-arterial | 459 |
| 151 | tace/intra-arterial | 1 |
| 152 | intraarterial | 115 |
| 153 | intrarterial | 2 |
| 154 | l-essential | 1 |
| 155 | non-liposomal | 3 |
| 156 | post-intradermal | 2 |
| 157 | intraputaminal | 2 |
| 158 | intraruminal | 13 |
| 159 | intrajejunal | 10 |
| 160 | cvc-peripheral | 2 |
| 161 | anti-rotaviral | 4 |
| 162 | sublingual/oral | 2 |
| 163 | intravenous/oral | 26 |
| 164 | nonfemoral | 2 |
| 165 | intra-pleural | 3 |
| 166 | intrapleural | 109 |
| 167 | epineural | 6 |
| 168 | intra-striatal | 1 |
| 169 | groups.rectal | 1 |
| 170 | intrarectal | 52 |
| 171 | prehopsital | 2 |
| 172 | oral/sublingual | 2 |
| 173 | propofolremifentanil | 1 |
| 174 | α-fluoromethyl | 1 |
| 175 | 3-carboranyl | 3 |
| 176 | decanoyl | 2 |
| 177 | ranibizumab/sham | 5 |
| 178 | /100-microgram | 1 |
| 179 | gbcm | 4 |
| 180 | naloxan | 1 |
| 181 | parturientsgiven | 1 |
| 182 | oxygen-driven | 6 |
| 183 | air-driven | 12 |
| 184 | heliox-driven | 10 |
| 185 | caerulein | 2 |
| 186 | riboprotein | 2 |
| 187 | glucose-potassium-insulin | 1 |
| 188 | ischemia/5-min | 3 |
| 189 | ischemia/45-min | 1 |
| 190 | ischaemia/75-min | 1 |
| 191 | antibiotin | 1 |
| 192 | tragopogon | 2 |
| 193 | o2/n2o | 4 |
| 194 | acylureido | 2 |
| 195 | oa/no | 1 |
| 196 | d-chiro | 2 |
| 197 | mailuo | 9 |
| 198 | slow-drop | 3 |
| 199 | equiosmolar | 7 |
| 200 | hypoosmolar | 3 |
| 201 | intravenous/intramuscular | 1 |
| 202 | intra-annular | 2 |
| 203 | isotopic-tracer | 1 |
| 204 | post-radiotracer | 1 |
| 205 | bent-over | 1 |
| 206 | 36-hr | 1 |
| 207 | post-nadir | 1 |
| 208 | dox/dnr | 1 |
| 209 | mnps-fe₃o₄and/or | 1 |
| 210 | leukocyte-poor | 3 |
| 211 | 160-detector | 1 |
| 212 | 1-2-hour | 1 |
| 213 | donor-feces | 1 |
| 214 | amebicides | 1 |
| 215 | gcsfs | 1 |
| 216 | at1/apoptosis | 1 |
| 217 | post-23vps | 1 |
| 218 | pre-bypass | 4 |
| 219 | public-access | 1 |
| 220 | intrathrombus | 4 |
| 221 | 2mg/bolus | 1 |
| 222 | intramuscular/subcutaneous | 2 |
| 223 | central-venous | 2 |
| 224 | intravenous | 13,381 |
| 225 | 'intravenous | 6 |
| 226 | non-intravenous | 2 |
| 227 | intravenosus | 1 |
| 228 | hxrxxs/t | 1 |
| 229 | test-product | 1 |
| 230 | dose-weight | 1 |
| 231 | conventional-dose-weight | 1 |
| 232 | ul13-dependent | 1 |
| 233 | 2-5a-dependent | 1 |
| 234 | open-vent | 3 |
| 235 | opioid-antagonist | 1 |
| 236 | hib/mcc-tt | 1 |
| 237 | 10u | 1 |
| 238 | 5000-iu | 2 |
| 239 | post-iv | 2 |
| 240 | anti-sftsv | 1 |
| 241 | intra-pulmonary | 1 |
| 242 | intracoronary | 908 |
| 243 | hepaticartery | 1 |
| 244 | definity | 6 |